Biotechnology Company Locates U.S. Division in North Carolina.

Medicago USA officially opens high-tech vaccine manufacturing facility in RTP.

11/14/2011

[North Carolina Department of Commerce Editorial Staff]

Medicago, Inc. celebrated the opening of its U.S.-based, state-of-the-art vaccine facility in Research Triangle Park today in a ribbon-cutting ceremony, according to a company press release.  Medicago USA officials were joined by guests Governor Bev Perdue, Secretary Keith Crisco, U.S. Senator Richard Burr and Congressman David Price at the event, which included a tour.

According to the release, the 97,000-square-foot, Virus-Like Particle (VLP), plant-based vaccine facility includes a fully-automated greenhouse and state-of-the-art extraction and purification unit. The Medicago USA operation is targeted to produce 10 million doses of pandemic influenza vaccine per month. In addition, it will have the production capacity of 40 million doses of seasonal Influenza vaccine or 120 million doses of pandemic influenza vaccine annually.

By using VLP and advanced technology methods, Medicago USA is able to produce pandemic vaccines in about a month. Traditional methods take four to six months by comparison. In addition, the process is less costly.

"Our rapid development and effectiveness of our vaccine candidates combined with our proven ability to build a vaccine facility in less than a year at a lower cost than traditional technologies are compelling advantages to potential partners and government agencies," said Andy Sheldon, President and CEO of Medicago, in an earlier press release.

In addition to the new North Carolina facility, Medicago, Inc. operates a 24,000-square-foot production facility in the Technology Park in Quebec City, Canada.  The biotechnology company focuses on the development of highly-effective, affordable vaccines based on proprietary manufacturing technologies and VLPs.

Additional information about Medicago, Inc., the Medicago USA/DARPA Agreement and Medicago, Inc.’s clinical program are available at www.medicago.com.

Sign up for ThriveNC's industry announcement alerts: SUBSCRIBE

Related news:
Ferraro Foods Chooses Mebane for State-of-the-Art Facility.
CMS Food Solutions Expands Biotech Manufacturing with New N.C. Plant.
North Carolina Is Second Most Innovative State in America. 

Related links:
Biotechnology Industry Workforce
VIDEO: N.C.'s Biotech-Pharma Industry Infrastructure
AccessNC™ Mobile App